Related Experiment Video

Updated: Jul 15, 2026

Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

STREPTOMYCIN AS AN ANTIVIRAL AGENT: MODE OF ACTION

T D BROCK, S O WOOLEY

    Science (New York, N.Y.)
    |September 13, 1963
    PubMed

    Insights

    Streptomycin antibiotic inhibits phage injection into resistant bacteria. This process is reversed by cations, polyamines, and streptidine, which may displace streptomycin from phage DNA, enabling injection.

    Area of Science:

    • Bacteriology
    • Virology
    • Molecular Biology

    Background:

    • Antibiotic resistance in bacteria poses a significant challenge.
    • Bacteriophages (phages) are viruses that infect bacteria.
    • Understanding phage-host interactions is crucial for developing new antimicrobial strategies.

    Purpose of the Study:

    • To investigate the mechanism by which streptomycin inhibits phage replication in resistant bacteria.
    • To identify factors that can reverse streptomycin's inhibitory effect on phage injection.

    Main Methods:

    • Experiments were conducted using streptomycin-resistant bacterial hosts.
    • Phage replication and injection processes were monitored in the presence and absence of streptomycin.
    • The effects of divalent cations, polyamines, and streptidine on phage injection were assessed.

    Main Results:

    • Streptomycin was found to inhibit phage injection into resistant bacteria.
    • This inhibition was competitively reversed by divalent cations, polyamines, and streptidine.
    • A proposed mechanism involves streptomycin binding to phage DNA within the phage head, preventing its unfolding for injection.

    Conclusions:

    • Streptomycin inhibits phage injection by interfering with phage DNA conformation.
    • Reversal agents likely displace streptomycin and promote phage injection.
    • This study sheds light on the intricate mechanisms of phage-host-antibiotic interactions.
    Keywords:
    AGARCALCIUMCOLIPHAGESDNA, VIRALEXPERIMENTAL LAB STUDYMAGNESIUMSPERMINESTREPTOCOCCUSSTREPTOMYCINVIRUS CULTIVATION

    More Related Videos

    Assay Development for High-Throughput Drug Screening Against Mycobacteria07:50

    Assay Development for High-Throughput Drug Screening Against Mycobacteria

    Published on: October 25, 2024

    Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

    Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

    Published on: May 9, 2025

    Related Concept Videos

    Principles of Drug Action01:24

    Principles of Drug Action

    Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
    Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
    Targets for Drug Action: Overview01:26

    Targets for Drug Action: Overview

    Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
    Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
    Combined Effects of Drugs: Synergism01:27

    Combined Effects of Drugs: Synergism

    Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
    Such synergistic combinations...
    Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

    Pharmacokinetics: Drug–Food and Drug–Viral Interactions

    A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
    Inhibitors of Viral Protein Synthesis01:30

    Inhibitors of Viral Protein Synthesis

    Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
    Antiviral Nucleoside Inhibitors01:22

    Antiviral Nucleoside Inhibitors

    Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...